Abstract Glucagon-like peptide 1 (GLP-1), an incretin hormone that reduces food intake, was
recently established as a novel regulator of alcohol-mediated behaviors. Clinically available …

Development of alcohol use disorders largely depends on the effects of alcohol on the brain
reward systems. Emerging evidence indicate that common mechanisms regulate food and …

Glucagon-like-peptide-1 (GLP-1) is a gut-and neuro-peptide with an important role in the
regulation of food intake and glucose metabolism. Interestingly, GLP-1 receptors (GLP-1R) …

Abstract Glucagon-like peptide-1 (GLP-1) is a gut peptide that regulates food intake and
glucose metabolism. GLP-1 is also produced and released in the brain, and GLP-1 …

Approximately 14.4 million Americans are experiencing alcohol use disorder (AUD) and
about two-thirds of people who experience drug addiction will relapse, highlighting the need …

Background The misuse and abuse of alcohol is a major public health issue. However,
available treatments are limited with variable efficacy. Recently, preclinical studies show that …

Glucagon-like peptide 1 (GLP-1) is an incretine hormone that controls consummatory
behavior and glucose homeostasis. It is released in response to nutrient ingestion from the …

The incretin hormone, glucagon‐like peptide 1 (GLP‐1), regulates gastric emptying, glucose‐
dependent stimulation of insulin secretion and glucagon release, and GLP‐1 analogs are …

The ability of glucagon-like peptide-1 (GLP-1) to reduce food intake involves activation of
GLP-1 receptors (GLP-1R) in the nucleus of the solitary tract (NTS). It has also been …

Alcohol addiction, affecting approximately four percent of the population, contributes
significantly to the global burden of diseases and is a substantial cost to the society. The …